1571 - 1580 of 4301 Drugs
Dapzura RT (daptomycin in sodium chloride injection)
Dapzura RT (daptomycin for injection) is a lipopeptide antibacterial indicated for the treatment of complicated skin and skin structure infections (cSSSI) in adult and pediatric patients (1 to 17 years of age); Staphylococcus aureus bloodstream infections (bacteremia), in adult patients including those with right-sided infective endocarditis; and Staphylococcus aureus bloodstream infections (bacteremia) in pediatricpatients (1 to 17 years of age).
Daraprim (pyrimethamine)
Daraprim (pyrimethamine) is an antiparasitic drug used to treat and prevent malaria, and is also used in the treatment of toxoplasmosis.
Darzalex Faspro (daratumumab and hyaluronidase-fihj injection)
Darzalex Faspro (daratumumab and hyaluronidase-fihj) is a combination of a CD38-directed cytolytic antibody and an endoglycosidase used to treat adult patients with multiple myeloma in combination with bortezomib, melphalan and prednisone in newly diagnosed patients who are ineligible for autologous stem cell transplant; in combination with lenalidomide and dexamethasone in newly diagnosed patients who are ineligible for autologous stem cell transplant and in patients with relapsed or refractory multiple myeloma who have received at least one prior therapy; in combination with bortezomib and dexamethasone in patients who have received at least one prior therapy; and as monotherapy, in patients who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory agent.
Darzalex (daratumumab intravenous injection)
Darzalex (daratumumab) injection is a human CD38-directed monoclonal antibody indicated for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double-refractory to a PI and an immunomodulatory agent.
Quviviq (daridorexant tablets)
Quviviq (daridorexant) is an orexin receptor antagonist indicated for the treatment of adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance.
Enablex (darifenacin extended-release tablets)
Enablex (darifenacin) is a urinary antispasmodic used to treat symptoms of overactive bladder, such as frequent or urgent urination, and incontinence (urine leakage).
Nubeqa (darolutamide tablets)
Nubeqa (darolutamide) is an androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Dartisla ODT (glycopyrrolate orally disintegrating tablets)
Dartisla ODT (glycopyrrolate) is an anticholinergic indicated in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer.
Prezista (darunavir)
Prezista (darunavir) is a type of antiviral medication called a protease inhibitor used to treat HIV, which causes acquired immunodeficiency syndrome (AIDS).
Prezcobix (darunavir and cobicistat tablets)
Prezcobix (darunavir and cobicistat) is a combination of a human immunodeficiency virus (HIV-1) protease inhibitor and a CYP3A inhibitor and is indicated for the treatment of HIV-1 infection in adult patients.